Printer Friendly

Browse Blood coagulation factors topic

Genetic aspects subtopic


1-16 out of 16 article(s)
Title Author Type Date Words
Association of Factor V Leiden G1691A and Prothrombin gene G20210A mutations with adverse pregnancy outcomes. Ali, Sidra Asad; Moiz, Bushra; Sheikh, Lumaan Report Jul 13, 2021 2753
Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients. El-Ghonemy, Mohamed S.; Sharawy, Solafa El; Fahmi, Maryan Waheeb; El-Ashwah, Shaimaa; Denewer, May; Apr 30, 2020 3978
Thrombotic disorders (part 2). Alli, N.A.; Vaughan, J.; Louw, S.; Schapkaitz, E.; Jacobson, B. Mar 1, 2020 5555
Massively Parallel Sequencing of a Chinese Family with DFNA9 Identified a Novel Missense Mutation in the LCCL Domain of COCH. Gu, Xiaodong; Su, Wenling; Tang, Mingliang; Guo, Luo; Zhao, Liping; Li, Huawei Report Jan 1, 2017 2404
Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report. Valjevac, Amina; Mehic, Bakir; Kiseljakovic, Emina; Ibrulj, Slavka; Garstka, Agnieszka; Adler, Grazy Report Feb 1, 2013 2274
Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries. Adler, Grazyna; Clark, Jeremy S.C.; Loniewska, Beata; Czerska, Ewa; Salkic, Nermin N.; Ciechanowicz, Report May 1, 2012 4607
Thrombophilia. Levy, Howard P. Apr 1, 2009 566
Factor V Leiden testing not advised by genetics experts. MacNeil, Jane Salodof Apr 1, 2008 527
Factor V 1691 G-A mutation distribution in a healthy Turkish population/Saglikli Turk populasyonunda faktor V (1691 G-A) mutasyon sikligi. Akar, Nejat Report Mar 1, 2008 2044
Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis/Kombine heterozigot faktor V Leiden mutasyonu ve antikardiyolipin antikor pozitifligi olan genc bir hastada derin ven trombozu. Karadurmus, Nuri; Ozturk, Cengiz; Sonmez, Alper; Dogru, Teoman; Inal, Satilmis; Tasci, Canturk; Oztu Case study Feb 1, 2008 1269
Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Castello, Remedios; Estelles, Amparo; Vazquez, Carlos; Falco, Cristina; Espana, Francisco; Almenar, Aug 1, 2002 5185
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. (Original Articles). Van Cott, Elizabeth M.; Soderberg, Britt L.; Laposata, Michael May 1, 2002 5064
Coagulation and bleeding disorders: review and update. Triplett, Douglas A. Aug 1, 2000 6946
Activated protein C resistance: automated detection of the factor V leiden mutation by mismatch hybridization. Klingler, Karl R.; Junold, Thomas; Wielckens, Klaus Nov 1, 1999 3933
Rapid, homogeneous genotyping of the 4G/5G polymorphism in the promoter region of the PAI1 gene by fluorescence resonance energy transfer and probe melting curves. Nauck, Markus; Wieland, Heinrich; Marz, Winfred Aug 1, 1999 4677
Blood clot agent's genes are read. Aug 15, 1987 364

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |